Cimpress plc is a US-listed company in the commercial printing industry. Its financial year ends in June.
Loading chart…
Third-party market data · may be delayed
~$99
Cash-flow model
Base case. Range ~$58–$150 across our lower- and higher-growth cases (3.4%–13.4% a year).
Undervalued
The price is below our entire value range; our base value is 73% above it.
Price used: $57.20, November 2, 2026
Cimpress plc valuation: adjust assumptions and compare models →
What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.
Revenue for the twelve months to September 2026 was $3.81bn, up 10.0% on a year earlier, about the same pace as a quarter earlier. Free-cash-flow margin fell to 5.0% from 6.4% a year earlier. Against its peers on growth, profitability, cash generation and balance sheet, it grades C. It passes 0 of our 4 financial-health checks. Our cash-flow model value is $99.48 a share.
Source: 10-Q filed October 29, 2026 on SEC EDGAR · Financials · Valuation
Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.
Cimpress plc's trailing-twelve-month revenue grew 10.0% year on year, with a free-cash-flow margin of 5.0%. Where it stands out: revenue growth of 10.0% ranks 1 of 5 commercial printing companies we cover.
Our discounted-cash-flow model values the business at ~$99 per share in the base case (~$58–$150 across growth scenarios) — model values under stated assumptions, not a price target.
Current signal Free cash flow diverging from earnings: TTM free cash flow fell 13.4% while net income grew 143.5%: a 157pp divergence.
Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.
Loading chart…
Third-party market data · may be delayed
Company announcements, filed results and changes that matter to shareholders.
The share price implies about 2.9% a year of cash-flow growth for five years.That is close to the 5.7% a year revenue growth Cimpress has delivered.
Our cash-flow model with every input fixed except growth over the next five years, solved for the growth at which the model value equals the share price ($56.61, Nov 3, 2026). Cash-flow growth then fades to 2.5% a year; discount rate 8.5%. Delivered figures are revenue growth from SEC filings. This is a model exercise, not investment advice or a forecast of the share price. All companies
Our value per share comes from a discounted-cash-flow model of Cimpress plc's free cash flow after stock-based pay ( $175M, FY2027 Q1 TTM, with after-tax interest added back): growth for five years as below (the first two years from forecasts, guidance and the company's record), fading to 2.5%, discounted at 8.5%, then cash added and debt and other claims subtracted. These are model values under stated assumptions, not price targets or recommendations.
We value Cimpress plc as an operating company, with every model that fits that kind of business. Cost of equity 9.1%: the 10-year Treasury yield (4.9%) plus a beta of 0.93 times a 4.5% equity risk premium.
| Model | Value per share | In the combined value? |
|---|---|---|
| Cash-flow model (DCF) Free cash flow to the firm (after stock pay, with after-tax interest added back), grown then faded to 2.5%, discounted at 8.5% as the firm rate, less debt and other claims. | ~$99 ~$58–$150 | Primary model, counts double |
| Price-to-earnings vs peers Earnings per share times peers' typical (harmonic-mean) price-to-earnings. | ~$56 ~$45–$95 | Included |
| Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. | — | Does not apply: book value or earnings not available |
| Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. | — | Does not apply: return on equity is not positive |
| Combined value Weighted average of the models that apply: the primary model (cash-flow model (dcf)) counts double. Models more than 5x or less than 0.2x the share price, or more than 3x away from the other models' median, are left out. | ~$85 ~$56–$99 | 2 models |
Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Cimpress plc with Industrials sector in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.
| Discount rate ↓ / growth → | −5% growth | 0% growth | 5% growth | 10% growth | 15% growth | 20% growth |
|---|---|---|---|---|---|---|
| 7% | $35 | $72 | $120 | $184 | $268 | $375 |
| 8.5% | $11 | $38 | $73 | $119 | $178 | $254 |
| 10% | — | $17 | $44 | $79 | $124 | $182 |
| At fiscal year end | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Now |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share price | $92.48 | $94.53 | $144.96 | $90.89 | $76.34 | $108.41 | $38.90 | $59.48 | $87.61 | $47.00 | $101.70 | $57.20 |
| Market value | $3.1bn | $3.0bn | $4.7bn | $2.9bn | $2.1bn | $2.8bn | $1.0bn | $1.6bn | $2.4bn | $1.2bn | $2.6bn | $1.4bn |
| + Net debt (− = net cash) | $630m | $886m | $854m | $1.1bn | $1.4bn | $1.6bn | $1.4bn | $1.5bn | $1.4bn | $1.4bn | $1.4bn | $1.5bn |
| Enterprise value | $3.7bn | $3.8bn | $5.5bn | $4.0bn | $3.5bn | $4.4bn | $2.4bn | $3.1bn | $3.8bn | $2.6bn | $4.0bn | $3.0bn |
| Multiples | ||||||||||||
| Price / sales | 1.7x | 1.4x | 1.8x | 1.0x | 0.9x | 1.1x | 0.4x | 0.5x | 0.7x | 0.4x | 0.7x | 0.4x |
| Price / earnings | 56.2x | — | 106.8x | 30.3x | 25.4x | — | — | — | 13.6x | 80.6x | 26.9x | 16.8x |
| Price / free cash flow | 18.3x | 35.8x | 35.5x | 11.0x | 7.4x | 12.4x | 6.1x | 20.4x | 8.0x | 5.8x | 14.0x | 7.5x |
| EV / EBITDA | 17.5x | 34.1x | 16.9x | 11.8x | 15.7x | 14.8x | 11.0x | 14.0x | 9.5x | 7.0x | 9.8x | 7.7x |
Moderate moat
How hard Cimpress's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.
Cash operating profit has been a median 26.7% of total assets over 10 years.
Gross margin has been a median 48.8%, moving by 1.6 percentage points (standard deviation) across 10 years.
Operating margin has been a median 4.0%; its worst year was 0.4%.
Free cash flow was positive in 10 of 10 years, at a median 5.6% of revenue.
The diluted share count fell 3.7% over five years; stock-based pay has been a median 1.6% of revenue.
AI disruption exposure: Medium. In this industry, AI could change how the product is made or sold, without replacing the core asset. The score above includes a 5-point deduction for that exposure (69 before it).
| Fiscal year | EPS | Growth | Revenue | Growth |
|---|---|---|---|---|
| Current | $5.00 | +32% | $4.0bn | +7% |
| Next | $7.67 | +54% | $4.2bn | +5% |
Next year's EPS estimate has moved −7.8% in 90 days, across 2 analysts.
The consensus EPS forecast for the current fiscal year is −2.8% on 90 days ago. In the last 30 days, 0 analysts raised Cimpress plc's forecast and 2 cut it.
Average of analysts' published estimates (third-party data).
| Period | Current fiscal year | Next fiscal year |
|---|---|---|
| 90 days ago | $5.14 | $8.32 |
| 60 days ago | $5.00 | $7.67 |
| 30 days ago | $5.00 | $7.67 |
| 7 days ago | $5.00 | $7.67 |
| Now | $5.00 | $7.67 |
| Quarter to | Estimate | Actual | Surprise |
|---|---|---|---|
| Sept 2026 | $0.81 | −$0.11 | −113.7% |
| Jun 2026 | $1.22 | $0.97 | −20.2% |
| Mar 2026 | $0.17 | $0.55 | +214.3% |
| Dec 2025 | $1.64 | $1.95 | +18.9% |
Adjusted EPS as companies report it, against the average analyst estimate.
Our cash-flow model grows Cimpress plc's revenue by +7.4% next year and +7.8% the year after, then fades back toward its own record by year five. Next year's rate weighs analysts' consensus (+6.7%, weight 56%) and the company's own record (+8.4%, weight 44%) . How the weights are set.
Last 12 months −17.4%
| Part | Then | Now | Effect |
|---|---|---|---|
| Revenue (last 12 months) | $3.4bn | $3.7bn | +9.8% |
| Net margin | 0.4% | 2.6% | +484.0% |
| P/E multiple | 118.7x | 15.1x | −87.3% |
| Share count | 26m | 25m | +1.2% |
Biggest factor: p/e multiple.
Last 3 years −8.2%
| Part | Then | Now | Effect |
|---|---|---|---|
| Revenue (last 12 months) | $3.1bn | $3.7bn | +21.3% |
| P/S multiple | 0.5x | 0.4x | −27.0% |
| Share count | 26m | 25m | +3.7% |
Biggest factor: p/s multiple. Loss-making at one end, so the split uses price/sales.
| Calendar year | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 to date |
|---|---|---|---|---|---|---|
| Return | ||||||
| CMPR | −18% | −61% | +190% | −10% | −7% | −14% |
| Industry peers (median) | +13% | +2% | +33% | +17% | −8% | +18% |
| S&P 500 | +29% | −18% | +26% | +25% | +18% | +11% |
| Months that ended higher | ||||||
| CMPR | 50% | 25% | 75% | 42% | 42% | 46% |
| S&P 500 | 75% | 42% | 67% | 75% | 75% | 46% |
| Largest fall from a high during the year | ||||||
| CMPR | −45% | −74% | −21% | −32% | −48% | −46% |
| S&P 500 | −5% | −25% | −10% | −8% | −19% | −9% |
Worst fall since November 2, 2015: 89% from March 9, 2018 to October 27, 2022. Getting back needed a 788% gain, and the shares have not yet recovered.
| Results released | Next day | S&P 500 next day | 5 days | 21 days |
|---|---|---|---|---|
| October 28, 2026 | −25.3% | 0.0% | — | — |
| July 29, 2026 | −5.4% | +0.1% | +0.6% | −11.1% |
| April 30, 2026 | +15.1% | +1.3% | +13.0% | +21.5% |
| January 28, 2026 | −0.7% | −0.2% | −4.6% | −7.0% |
| October 29, 2025 | +11.2% | −1.1% | −3.0% | +3.2% |
| July 29, 2025 | +12.4% | −0.4% | +11.8% | +27.0% |
| April 30, 2025 | −8.1% | +0.7% | −3.2% | +3.7% |
| January 29, 2025 | −3.7% | +0.1% | −20.5% | −34.0% |
| October 30, 2024 | −8.7% | −2.3% | +7.0% | +6.2% |
| July 31, 2024 | +4.7% | +0.2% | −8.3% | +9.7% |
| May 1, 2024 | −3.1% | +0.6% | −0.5% | −3.2% |
| January 31, 2024 | +17.2% | −0.3% | +8.3% | +27.6% |
How Cimpress plc’s listed options are priced, and three ways to use them that follow from our valuation. Quotes are delayed, read November 2, 2026. Check the live chain at your broker before trading.
Not offered: fundamentals grade B (needs B+ or better).
We suggest selling a put only on well-rated companies, at a strike where the price you would pay if assigned (strike less premium) is at or below our fair value.
Not offered: no liquid call at or above our price target — the model says the upside is worth more than any listed strike.
For holders: sell a call at a strike at or above our fair value, so the shares are only sold at a price the model calls full value.
Not offered: the shares trade below our fair value: a collar caps upside the model expects.
For holders of a stock trading at or above our fair value: buy a put for a floor and sell a call to pay for it.
General research, not personal advice. Options can lose you more than you expect and are not suitable for everyone: put sellers can be made to buy shares that keep falling, call sellers give up gains above the strike, and results or news can move prices sharply. Chances shown are approximations from each option’s delta. Spreads, fees and early assignment are not modelled.
Source: SEC EDGAR filings. Retrieved October 31, 2026.
| Period | Revenue (TTM) |
|---|---|
| FY24 Q2 | $3.2B |
| FY24 Q3 | $3.2B |
| FY24 Q4 | $3.3B |
| FY25 Q1 | $3.3B |
| FY25 Q2 | $3.4B |
| FY25 Q3 | $3.4B |
| FY25 Q4 | $3.4B |
| FY26 Q1 | $3.5B |
| FY26 Q2 | $3.6B |
| FY26 Q3 | $3.7B |
| FY26 Q4 | $3.7B |
| FY27 Q1 | $3.8B |
Source: SEC EDGAR filings. Retrieved October 31, 2026.
| Period | Revenue growth, TTM YoY |
|---|---|
| FY24 Q2 | 9.6% |
| FY24 Q3 | 7.8% |
| FY24 Q4 | 6.9% |
| FY25 Q1 | 6.6% |
| FY25 Q2 | 4.6% |
| FY25 Q3 | 3.6% |
| FY25 Q4 | 3.4% |
| FY26 Q1 | 3.6% |
| FY26 Q2 | 6.2% |
| FY26 Q3 | 8.8% |
| FY26 Q4 | 9.8% |
| FY27 Q1 | 10.0% |
Source: SEC EDGAR filings. Retrieved October 31, 2026.
| Period | Operating margin (TTM) |
|---|---|
| FY24 Q2 | 5.7% |
| FY24 Q3 | 7.2% |
| FY24 Q4 | 7.5% |
| FY25 Q1 | 7.6% |
| FY25 Q2 | 6.7% |
| FY25 Q3 | 6.7% |
| FY25 Q4 | 6.6% |
| FY26 Q1 | 6.8% |
| FY26 Q2 | 6.8% |
| FY26 Q3 | 6.9% |
| FY26 Q4 | 6.7% |
| FY27 Q1 | 6.0% |
Source: SEC EDGAR filings. Retrieved October 31, 2026.
| Period | FCF margin (TTM) |
|---|---|
| FY24 Q2 | 7.2% |
| FY24 Q3 | 7.0% |
| FY24 Q4 | 9.0% |
| FY25 Q1 | 7.9% |
| FY25 Q2 | 7.4% |
| FY25 Q3 | 7.0% |
| FY25 Q4 | 6.1% |
| FY26 Q1 | 6.4% |
| FY26 Q2 | 5.9% |
| FY26 Q3 | 5.1% |
| FY26 Q4 | 4.9% |
| FY27 Q1 | 5.0% |
Each dollar Cimpress took in during FY2026, followed through to profit: what it cost to make, what went on research and running the business, and what was left after tax.
| Revenue | $3.7B | |
|---|---|---|
| Cost of revenue | $2B | 53.7% of revenue |
| Gross profit | $1.7B | 46.3% of revenue |
| Research and development | $68.6M | 1.8% of revenue |
| Selling, general and admin | $1.1B | 29.6% of revenue |
| Other operating costs | $304M | 8.1% of revenue |
| Operating income | $251M | 6.7% of revenue |
| Income tax | $55.8M | 1.5% of revenue |
| Interest and other | $99.4M | 2.7% of revenue |
| Net income | $95.9M | 2.6% of revenue |
| Fiscal year | 2010 Jun 2010 | 2011 Jun 2011 | 2012 Jun 2012 | 2013 Jun 2013 | 2014 Jun 2014 | 2015 Jun 2015 | 2016 Jun 2016 | 2017 Jun 2017 | 2018 Jun 2018 | 2019 Jun 2019 | 2020 Jun 2020 | 2021 Jun 2021 | 2022 Jun 2022 | 2023 Jun 2023 | 2024 Jun 2024 | 2025 Jun 2025 | 2026 Jun 2026 | LTM Sept 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income | ||||||||||||||||||
| Revenue | 670 | 817 | 1,020 | 1,167 | 1,270 | 1,494 | 1,788 | 2,135 | 2,593 | 2,751 | 2,481 | 2,576 | 2,888 | 3,080 | 3,292 | 3,403 | 3,737 | 3,807 |
| Gross profit | 430 | 529 | 665 | 767 | 819 | 926 | 1,014 | 1,098 | 1,313 | 1,350 | 1,232 | 1,276 | 1,395 | 1,439 | 1,597 | 1,617 | 1,730 | 1,735 |
| EBITDA | 121 | 144 | 115 | 110 | 158 | 194 | 210 | 113 | 327 | 337 | 224 | 297 | 223 | 220 | 399 | 367 | 403 | 388 |
| Operating income | 77 | 93 | 55 | 46 | 86 | 96 | 78 | −46 | 158 | 164 | 56 | 124 | 47 | 57 | 247 | 226 | 251 | 228 |
| Net income | 68 | 82 | 44 | 29 | 44 | 92 | 54 | −72 | 44 | 95 | 83 | −85 | −54 | −186 | 174 | 15 | 96 | 86 |
| Diluted EPS | $1.49 | $1.83 | $1.13 | $0.85 | $1.28 | $2.73 | $1.64 | −$2.29 | $1.36 | $3.00 | $3.00 | −$3.28 | −$2.08 | −$7.08 | $6.43 | $0.58 | $3.79 | $3.40 |
| Growth (year on year) | ||||||||||||||||||
| Revenue | +29.9% | +21.9% | +24.9% | +14.4% | +8.8% | +17.6% | +19.7% | +19.4% | +21.4% | +6.1% | −9.8% | +3.8% | +12.1% | +6.7% | +6.9% | +3.4% | +9.8% | +10.0% |
| EBITDA | +24.6% | +18.6% | −20.3% | −3.6% | +43.2% | +22.5% | +8.4% | −46.4% | +190.0% | +3.0% | −33.5% | +32.5% | −24.9% | −1.5% | +81.6% | −7.9% | +9.7% | +2.5% |
| Operating income | +24.8% | +21.1% | −40.7% | −16.4% | +86.3% | +12.1% | −18.8% | −158.4% | — | +3.7% | −65.8% | +120.7% | −61.7% | — | — | −8.5% | +10.9% | −3.3% |
| Net income | +21.6% | +21.2% | −46.4% | −33.1% | +48.4% | +111.0% | −41.1% | −231.9% | — | — | −12.3% | −202.2% | — | — | — | −91.4% | — | — |
| Diluted EPS | +19.2% | +22.8% | −38.3% | −24.8% | +50.6% | +113.3% | −39.9% | −239.6% | — | — | 0.0% | −209.3% | — | — | — | −91.0% | — | — |
| Margins | ||||||||||||||||||
| Gross margin | 64.2% | 64.8% | 65.2% | 65.7% | 64.5% | 61.9% | 56.7% | 51.4% | 50.6% | 49.1% | 49.7% | 49.5% | 48.3% | 46.7% | 48.5% | 47.5% | 46.3% | 45.6% |
| EBITDA margin | 18.1% | 17.6% | 11.2% | 9.5% | 12.5% | 13.0% | 11.8% | 5.3% | 12.6% | 12.2% | 9.0% | 11.5% | 7.7% | 7.1% | 12.1% | 10.8% | 10.8% | 10.2% |
| Operating margin | 11.5% | 11.4% | 5.4% | 4.0% | 6.8% | 6.4% | 4.4% | −2.1% | 6.1% | 5.9% | 2.3% | 4.8% | 1.6% | 1.9% | 7.5% | 6.6% | 6.7% | 6.0% |
| Net margin | 10.1% | 10.1% | 4.3% | 2.5% | 3.4% | 6.2% | 3.0% | −3.4% | 1.7% | 3.5% | 3.4% | −3.3% | −1.9% | −6.0% | 5.3% | 0.4% | 2.6% | 2.2% |
| Free-cash-flow margin | 7.8% | 15.3% | 9.2% | 5.2% | 6.4% | 11.1% | 9.3% | 3.9% | 5.1% | 9.5% | 11.6% | 8.8% | 5.7% | 2.5% | 9.0% | 6.1% | 4.9% | 5.0% |
| Cash flow | ||||||||||||||||||
| Cash from operations | 154 | 163 | 141 | 140 | 154 | 242 | 247 | 157 | 192 | 331 | 338 | 265 | 220 | 130 | 351 | 298 | 284 | 288 |
| Capital spending | 101 | 37 | 46 | 79 | 72 | 76 | 80 | 74 | 61 | 71 | 50 | 39 | 54 | 54 | 55 | 89 | 100 | 97 |
| Free cash flow | 52 | 125 | 94 | 61 | 82 | 166 | 167 | 83 | 131 | 261 | 288 | 227 | 165 | 77 | 296 | 209 | 183 | 191 |
| Stock-based pay | 22 | 22 | 25 | 33 | 28 | 24 | 24 | 49 | 50 | 22 | 35 | 37 | 50 | 42 | 66 | 59 | 61 | 62 |
| Free cash flow after stock pay | 30 | 104 | 69 | 28 | 54 | 142 | 143 | 34 | 81 | 239 | 253 | 190 | 116 | 34 | 230 | 150 | 122 | 129 |
| Balance sheet | ||||||||||||||||||
| Cash | 237 | 237 | 62 | 50 | 63 | 104 | 77 | 26 | 44 | 35 | 45 | 183 | 277 | 130 | 204 | 234 | 249 | 120 |
| Total debt | 5 | 0 | 229 | 248 | 448 | 514 | 708 | 912 | 899 | 1,117 | 1,434 | 1,765 | 1,705 | 1,654 | 1,617 | 1,605 | 1,636 | 1,668 |
| Net debt (negative = net cash) | −231 | −237 | 167 | 197 | 386 | 411 | 630 | 886 | 854 | 1,082 | 1,389 | 1,582 | 1,428 | 1,524 | 1,413 | 1,371 | 1,388 | 1,548 |
| Diluted shares | 45m | 45m | 39m | 34m | 34m | 34m | 33m | 31m | 32m | 32m | 28m | 26m | 26m | 26m | 27m | 26m | 25m | 25m |
| Returned to shareholders | ||||||||||||||||||
| Buybacks | 0 | 57 | 310 | 64 | 42 | 0 | 153 | 50 | 95 | 56 | 627 | 0 | 0 | 0 | 157 | 78 | 50 | 47 |
| Total returned | 0 | 57 | 310 | 64 | 42 | 0 | 153 | 50 | 95 | 56 | 627 | 0 | 0 | 0 | 157 | 78 | 50 | 47 |
| Quarter | 2025 Q2 Dec 2024 | 2025 Q3 Mar 2025 | 2025 Q4 Jun 2025 | 2026 Q1 Sept 2025 | 2026 Q2 Dec 2025 | 2026 Q3 Mar 2026 | 2026 Q4 Jun 2026 | 2027 Q1 Sept 2026 |
|---|---|---|---|---|---|---|---|---|
| Income | ||||||||
| Revenue | 939 | 789 | 869 | 863 | 1,042 | 886 | 945 | 934 |
| Gross profit | 450 | 373 | 413 | 403 | 488 | 409 | 430 | 408 |
| EBITDA | 116 | 75 | 102 | 86 | 125 | 87 | 106 | 70 |
| Operating income | 81 | 41 | 65 | 49 | 88 | 49 | 65 | 26 |
| Net income | 61 | −8 | −25 | 8 | 49 | 14 | 25 | −3 |
| Diluted EPS | $2.36 | −$0.33 | −$0.98 | $0.30 | $1.95 | $0.55 | $0.98 | −$0.11 |
| Growth (year on year) | ||||||||
| Revenue | +1.9% | +1.1% | +4.4% | +7.2% | +11.0% | +12.3% | +8.7% | +8.2% |
| EBITDA | −20.9% | −1.9% | −0.5% | +14.3% | +7.4% | +15.7% | +4.4% | −17.9% |
| Operating income | −24.8% | +3.3% | −1.3% | +24.5% | +8.8% | +21.3% | −1.0% | −46.9% |
| Net income | +5.1% | — | −122.0% | — | −19.2% | — | — | — |
| Diluted EPS | +10.3% | — | −123.0% | — | −17.4% | — | — | — |
| Margins | ||||||||
| Gross margin | 47.9% | 47.2% | 47.5% | 46.7% | 46.8% | 46.2% | 45.5% | 43.7% |
| EBITDA margin | 12.4% | 9.5% | 11.7% | 9.9% | 12.0% | 9.8% | 11.2% | 7.5% |
| Operating margin | 8.6% | 5.1% | 7.5% | 5.7% | 8.5% | 5.5% | 6.9% | 2.8% |
| Net margin | 6.5% | −1.0% | −2.9% | 0.9% | 4.7% | 1.6% | 2.7% | −0.3% |
| Free-cash-flow margin | 16.0% | −1.9% | 10.0% | −0.1% | 13.4% | −4.5% | 9.0% | 0.7% |
| Cash flow | ||||||||
| Cash from operations | 177 | 10 | 107 | 25 | 165 | −17 | 111 | 29 |
| Capital spending | 26 | 25 | 21 | 26 | 25 | 23 | 26 | 23 |
| Free cash flow | 150 | −15 | 87 | −1 | 139 | −40 | 85 | 6 |
| Stock-based pay | 14 | 12 | 16 | 15 | 17 | 14 | 15 | 16 |
| Free cash flow after stock pay | 136 | −27 | 70 | −16 | 123 | −53 | 70 | −10 |
| Last 12 months unless stated | CMPR | QUAD | DLX | EBF | MGIH | Median |
|---|---|---|---|---|---|---|
| Revenue, last 12 months | $3.8bn | $2.4bn | $2.1bn | $397m | $20m | $2.1bn |
| Revenue growth, last 12 months | 10.0% | −4.9% | 0.3% | 2.3% | −19.7% | 0.3% |
| Revenue growth, 3-year average | 6.7% | −8.0% | −1.9% | −2.7% | — | −2.3% |
| Revenue growth, latest quarter | 8.2% | −0.2% | −4.2% | 3.4% | — | 1.6% |
| Gross margin | 45.6% | 21.4% | 52.5% | 30.6% | 8.1% | 30.6% |
| Operating margin | 6.0% | 3.5% | 11.9% | 13.6% | −36.3% | 6.0% |
| Operating margin, 3-year average | 6.8% | 2.3% | 9.8% | 13.3% | — | 8.3% |
| Net margin | 2.2% | 1.1% | 4.8% | 9.8% | −34.9% | 2.2% |
| Cash from operations / revenue | 7.6% | 3.5% | 14.3% | 17.2% | −22.1% | 7.6% |
| Free-cash-flow margin | 5.0% | 1.6% | 9.9% | 14.5% | −29.4% | 5.0% |
| Free-cash-flow margin, 3-year average | 6.4% | 1.4% | 7.3% | 13.8% | — | 6.9% |
| Stock pay / revenue | 1.6% | 0.3% | 1.3% | 0.5% | — | 0.9% |
| Change in share count | −1.7% | 3.0% | 2.3% | −2.2% | 0.0% | 0.0% |
| Measure | Company | Peer median | Rank |
|---|---|---|---|
| Revenue growth Growth | 10.0% | 0.3% | 1 of 5 |
| Change in growth rate Growth | +0.2pp | +1.0pp | 4 of 5 |
| Gross margin Profitability | 45.6% | 30.6% | 2 of 5 |
| Operating margin Profitability | 6.0% | 6.0% | 3 of 5 |
| Net margin Profitability | 2.2% | 2.2% | 3 of 5 |
| Free-cash-flow margin Cash generation | 5.0% | 5.0% | 3 of 5 |
| Change in share count Balance sheet | -1.7% | 0.0% | 2 of 5 |
Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).
| Line of business | Revenue | YoY |
|---|---|---|
| Vista Print | $1.9B | ▲ 6.0% |
| Print Brothers | $823M | ▲ 23.0% |
| National Pen | $447M | ▲ 9.7% |
| The Print Group | $446M | ▲ 17.5% |
| All Other Businesses | $258M | ▲ 13.3% |
These categories overlap or exclude eliminations, so shares aren't shown.
| Line of business | Revenue | Share | YoY |
|---|---|---|---|
| Physical Printed Products and Other | $3.7B | 98.4% | ▲ 10.5% |
| Digital Products and Services | $58.2M | 1.6% | ▼ 21.6% |
| Region | Revenue | YoY |
|---|---|---|
| Europe | $1.9B | ▲ 15.1% |
| North America | $1.7B | ▲ 4.3% |
| Other Countries | $1.6B | ▲ 14.6% |
| United States | $1.5B | ▲ 3.8% |
| Germany | $639M | ▲ 14.1% |
| Other Continents | $149M | ▲ 13.1% |
These categories overlap or exclude eliminations, so shares aren't shown.
From Cimpress plc's 10-K filed August 7, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.
| Manager | Value | Shares | Share of 13F value | Shares QoQ |
|---|---|---|---|---|
| Jupiter Topco LLC | $384M | 3.8M | 17.7% | — |
| Prescott General Partners LLC | $367M | 3.6M | 16.9% | 0.0% |
| Rubric Capital Management LP | $178M | 1.8M | 8.2% | ▲ 7.4% |
| Blackrock, Inc. | $137M | 1.3M | 6.3% | ▲ 2.3% |
| Spruce House Investment Management LLC | $124M | 1.2M | 5.7% | 0.0% |
| Vanguard Portfolio Management LLC | $87.4M | 860K | 4.0% | ▲ 1.5% |
| Vanguard Capital Management LLC | $74.7M | 735K | 3.4% | ▼ 1.4% |
| Acadian Asset Management LLC | $59.7M | 588K | 2.8% | ▲ 6.5% |
| Diamond Hill Capital Management, LLC (Investment Advisor) | $50.8M | 500K | 2.3% | ▼ 31.2% |
| Wasatch Advisors LP | $47.5M | 467K | 2.2% | New |
| Dimensional Fund Advisors LP | $46.2M | 455K | 2.1% | ▲ 1.7% |
| Geode Capital Management, LLC | $43M | 423K | 2.0% | ▲ 3.6% |
From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Cimpress plc's complete shareholder register. Values are as reported by the filers ; 1 inconsistently scaled filing rows were excluded.
From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.
No trades in Cimpress plc disclosed in the last 12 months; 3 earlier trades on record.
Next expected around January 27, 2027 estimated from the company's past filing pattern, not announced
| Data | Last updated | Source |
|---|---|---|
| Share price | Exchange closing prices | |
| Financial statements | SEC 10-K and 10-Q filings | |
| News and updates | Company releases and SEC 8-K filings | |
| Analyst estimates | Aggregated analyst estimates | |
| Valuation and scores | Our models, from the filed figures |
New research on the companies we cover arrives in the weekly email. Free, one email a week.
